Search Results for 'Medical research'

The clinical research facility at University Hospital Galway is marking International Clinical Trials Day on Saturday with an open day at its facility in the UHG campus.

NUI Galway researchers have been part of a large-scale clinical trial of statin treatment in patients with Acute Respiratory Distress Syndrome (ARDS) which was published this week in the New England Journal of Medicine (NEJM).

In a major boost for regenerative medicine research in Ireland, Minister for Enterprise, Trade, and Innovation, Batt O’Keeffe announced this week the funding of almost €10 million for the Regenerative Medicine Institute (REMEDI) at NUI Galway.

It is clear to most people in Galway that the medical device industry plays a fundamental role in the economic fabric of the city. Indeed, while visitors to the city may be surprised to overhear terms like ‘stent’, ‘biomedical device’ or ‘catheter’ rising out of countless conversations on Shop Street on Saturday afternoon, it is hardly surprising to locals who know that more than 6,000 are employed in the medical device sector in Galway. Indeed, if we look at the number of people indirectly employed this figure rises to about 10,000. No doubt every Galwegian knows someone who works in the medical device industry or a related industry.

Professor Larry Egan, Interim Director of the Health Research Board (HRB) Clinical Research Facility, Galway has welcomed the announcement that €7.5m in capital funding is being provided for the construction of a new Clinical Research Facility on the grounds of University Hospital Galway.

Professor Larry Egan, Interim Director of the Health Research Board (HRB) Clinical Research Facility, Galway has welcomed the announcement that €7.5m in capital funding is being provided for the construction of a new Clinical Research Facility on the grounds of University Hospital Galway.

Local medical device developer Crospon has reason to celebrate on the double with the news that it has secured an additional €2 million in funding and that its flagship gastroenterology product has received clearance from the US Food and Drugs Administration.